Apomorphine in the treatment of Parkinson's disease.
Publication
, Journal Article
Menon, R; Stacy, M
Published in: Expert opinion on pharmacotherapy
August 2007
Motor fluctuations, refractory to conventional medical management, are one of the most troubling aspects of Parkinson's disease. Apomorphine is a dopaminergic agent that has been known to the medical community for more than a century, but has only recently been developed to treat such motor fluctuations. In this article, the authors review the historical background, structure, mechanism of action, pharmacologic properties, clinical trials, indications and side effects, as well as avenues of further research, of apomorphine.
Published In
Expert opinion on pharmacotherapy
DOI
EISSN
1744-7666
ISSN
1465-6566
Publication Date
August 2007
Volume
8
Issue
12
Start / End Page
1941 / 1950
Related Subject Headings
- Randomized Controlled Trials as Topic
- Quality of Life
- Pharmacology & Pharmacy
- Parkinson Disease
- Humans
- Dyskinesias
- Drug Administration Routes
- Contraindications
- Apomorphine
- Antiparkinson Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Menon, R., & Stacy, M. (2007). Apomorphine in the treatment of Parkinson's disease. Expert Opinion on Pharmacotherapy, 8(12), 1941–1950. https://doi.org/10.1517/14656566.8.12.1941
Menon, Rukmini, and Mark Stacy. “Apomorphine in the treatment of Parkinson's disease.” Expert Opinion on Pharmacotherapy 8, no. 12 (August 2007): 1941–50. https://doi.org/10.1517/14656566.8.12.1941.
Menon R, Stacy M. Apomorphine in the treatment of Parkinson's disease. Expert opinion on pharmacotherapy. 2007 Aug;8(12):1941–50.
Menon, Rukmini, and Mark Stacy. “Apomorphine in the treatment of Parkinson's disease.” Expert Opinion on Pharmacotherapy, vol. 8, no. 12, Aug. 2007, pp. 1941–50. Epmc, doi:10.1517/14656566.8.12.1941.
Menon R, Stacy M. Apomorphine in the treatment of Parkinson's disease. Expert opinion on pharmacotherapy. 2007 Aug;8(12):1941–1950.
Published In
Expert opinion on pharmacotherapy
DOI
EISSN
1744-7666
ISSN
1465-6566
Publication Date
August 2007
Volume
8
Issue
12
Start / End Page
1941 / 1950
Related Subject Headings
- Randomized Controlled Trials as Topic
- Quality of Life
- Pharmacology & Pharmacy
- Parkinson Disease
- Humans
- Dyskinesias
- Drug Administration Routes
- Contraindications
- Apomorphine
- Antiparkinson Agents